Ligand Pharmaceuticals Crecimiento futuro
Future controles de criterios 4/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Ligand Pharmaceuticals de 35.5% y 15% respectivamente, mientras que el BPA crecerá en un 33.4% al año.
Información clave
35.5%
Tasa de crecimiento de los beneficios
33.4%
Tasa de crecimiento del BPA
Crecimiento de los beneficios de Pharmaceuticals | 23.7% |
Tasa de crecimiento de los ingresos | 15.0% |
Rentabilidad financiera futura | n/a |
Cobertura de analistas | Good |
Última actualización | 14 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies
Nov 24Market Participants Recognise Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Earnings
Oct 31Ligand Pharmaceuticals: Solid Performer Performing Solidly
Jul 29Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 18Should You Be Adding Ligand Pharmaceuticals (NASDAQ:LGND) To Your Watchlist Today?
Jun 29Subdued Growth No Barrier To Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) With Shares Advancing 27%
May 23Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio
Apr 30Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Not Flying Under The Radar
Dec 19Is Now The Time To Put Ligand Pharmaceuticals (NASDAQ:LGND) On Your Watchlist?
Jun 14We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
May 29Are Investors Undervaluing Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) By 45%?
May 07These 4 Measures Indicate That Ligand Pharmaceuticals (NASDAQ:LGND) Is Using Debt Reasonably Well
Jan 26We Think Ligand Pharmaceuticals (NASDAQ:LGND) Can Stay On Top Of Its Debt
Oct 21Ligand Pharmaceuticals: Struggling Along
Sep 25Growth Investors: Industry Analysts Just Upgraded Their Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Revenue Forecasts By 11%
Aug 11Here's Why Ligand Pharmaceuticals (NASDAQ:LGND) Can Manage Its Debt Responsibly
Jun 27Previsiones de crecimiento de beneficios e ingresos
Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
---|---|---|---|---|---|
12/31/2026 | 215 | 99 | 91 | 168 | 4 |
12/31/2025 | 183 | 63 | 60 | 137 | 6 |
12/31/2024 | 163 | 34 | 22 | 84 | 7 |
9/30/2024 | 152 | 45 | 25 | 77 | N/A |
6/30/2024 | 133 | 42 | -4 | 48 | N/A |
3/31/2024 | 118 | 96 | -17 | 34 | N/A |
12/31/2023 | 131 | 54 | -4 | 50 | N/A |
9/30/2023 | 154 | 21 | 90 | 95 | N/A |
6/30/2023 | 180 | 41 | 99 | 108 | N/A |
3/31/2023 | 204 | 51 | 104 | 120 | N/A |
12/31/2022 | 196 | -5 | 120 | 138 | N/A |
9/30/2022 | 183 | 23 | 95 | 112 | N/A |
6/30/2022 | 188 | 27 | 97 | 112 | N/A |
3/31/2022 | 223 | 45 | 110 | 120 | N/A |
12/31/2021 | 242 | 76 | 71 | 79 | N/A |
9/30/2021 | 275 | 68 | 45 | 52 | N/A |
6/30/2021 | 252 | 48 | 37 | 44 | N/A |
3/31/2021 | 208 | 39 | 42 | 48 | N/A |
12/31/2020 | 164 | 7 | 51 | 55 | N/A |
9/30/2020 | 143 | -16 | 41 | 47 | N/A |
6/30/2020 | 126 | -25 | 24 | 28 | N/A |
3/31/2020 | 110 | -61 | -60 | -58 | N/A |
12/31/2019 | 120 | 629 | 781 | -29 | N/A |
9/30/2019 | 153 | 594 | 812 | 11 | N/A |
6/30/2019 | 174 | 677 | 846 | 44 | N/A |
3/31/2019 | 239 | 764 | 980 | 179 | N/A |
12/31/2018 | 251 | 143 | 183 | 194 | N/A |
9/30/2018 | 242 | 179 | 198 | 193 | N/A |
6/30/2018 | 230 | 120 | N/A | 193 | N/A |
3/31/2018 | 168 | 53 | N/A | 130 | N/A |
12/31/2017 | 141 | 13 | N/A | 89 | N/A |
9/30/2017 | 129 | 16 | N/A | 78 | N/A |
6/30/2017 | 117 | 9 | N/A | 69 | N/A |
3/31/2017 | 109 | -3 | N/A | 69 | N/A |
12/31/2016 | 109 | -2 | N/A | 61 | N/A |
9/30/2016 | 92 | 7 | N/A | 56 | N/A |
6/30/2016 | 88 | 205 | N/A | 48 | N/A |
3/31/2016 | 87 | 235 | N/A | 47 | N/A |
12/31/2015 | 72 | 230 | N/A | 42 | N/A |
9/30/2015 | 74 | 231 | N/A | 38 | N/A |
6/30/2015 | 71 | 33 | N/A | 32 | N/A |
3/31/2015 | 63 | 11 | N/A | 26 | N/A |
12/31/2014 | 65 | 12 | N/A | 21 | N/A |
9/30/2014 | 56 | 7 | N/A | 22 | N/A |
6/30/2014 | 54 | 8 | N/A | 18 | N/A |
3/31/2014 | 53 | 10 | N/A | 21 | N/A |
12/31/2013 | 49 | 9 | N/A | 21 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (35.5% al año) de LGND es superior a la tasa de ahorro (2.6%).
Beneficios vs. Mercado: Se prevé que los beneficios (35.5% al año) de LGND crezcan más rápidamente que el mercado US (15.4% al año).
Beneficios de alto crecimiento: Se espera que los beneficios de LGND crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (15% al año) de LGND crezcan más rápidamente que los del mercado US (8.9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 15% al año) de LGND crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de LGND se prevé que sea elevada dentro de 3 años.